You searched for "Referrals"

1506 results found

A randomised, controlled trial of oral propranolol in infantile haemangioma

Since its use was first reported in the New England Journal in 2008, propranolol has become the preferred treatment for infantile haemangiomas. However, there is no consensus as to the optimum dose or duration of treatment and there is a...

Diagnosis and management of solitary fibrous tumour

This is a retrospective review of 21 patients diagnosed with solitary fibrous tumour of the orbit between 1996 and 2018 at a single centre. The authors reviewed the clinical presentation, management and course of the disease and reanalysed the histopathology...

Mobile phone use with esotropia development

This study analysed clinical characteristics and surgical outcomes in patients with acquired comitant esotropia (ACET) and determined the prevalence of excessive mobile touch screen device use in these patients. This was a retrospective study of 35 patients of which three...

SS-OCT assessment of ITC after phacoemulsification

This is a multicentre randomised controlled trial of 22 patients with primary angle closure glaucoma with peripheral anterior synechia and peripheral primary angle closure glaucoma (PACG) with peripheral anterior synechia (PAS) detected by indentation gonioscopy was randomised into two groups....

Effect of selenium and vitamin E supplements on the development and progression of cataracts

The Selenium and Vitamin E Cancer Prevention Trial (SELECT) investigated the influence of dietary supplements on the development of prostate cancer in a group of 35,533 middle aged and older, apparently healthy men. The SELECT Eye Endpoint (SEE) study is...

Is there an association between dry eye disease and depression and anxiety?

Dry eye disease is a widespread ocular surface condition (prevalence 5.5-33.7%) that has been previously linked to systemic diseases, such as Sjogren, rheumatoid arthritis and more recently possibly also depression, in small population-based studies. The authors’ aim was to investigate...

DISC lens slow myopia progression in Hong Kong Chinese schoolchildren

This is a prospective double-blind randomised trial between September 2007 and October 2009. It included 221 children aged 8-13 years, with myopia between -1 and -5 Dioptres ≤1.00D. There were 111 patients in the defocus incorporated soft contact DISC group...

DRIL after macular oedema treatment in BRVO

The authors report the analysis of a single-site, retrospective, cross-sectional study to evaluate the association between disorganisation of the retinal inner layers (DRIL) and visual acuity (VA) after anti-VEGF treatment for macular oedema (MO) due to branch retinal vein occlusion...

VIBIM Study: One-year results of treatment of DME with aflibercept using TnE

The VIBIM study (the treat-and-extend regimen (TER) using intravitreal aflibercept in diabetic macular edema (DME) study) was designed to evaluate the efficacy of the TER using aflibercept in the management of DME for a period of two years. The authors...

Simplified Ophthalmic Statistics (SOS) Part 1: An introduction to data – how do we classify it and why does it matter?

Introductory statistics courses often start by explaining how data can be classified in different ways. What is not always clear is why you would need to know this. Catey Bunce and Tafadzwa Young-Zvandasara explain. The term data can be applied...

Save the date for the SEE Summit

The Association of British Dispensing Opticians (ABDO) is calling on everyone across the optical professions and industry to save 9 October 2023 for the third SEE Summit on the Environment.

Applications closing soon for leadership and management training and qualifications

Optical professionals who want to boost their career in management are encouraged to apply now for the leadership and management courses from the Association of British Dispensing Opticians (ABDO). Study is carried out 100% online and the closing date for applications for training leading to these qualifications is Thursday 4 April 2024.